{"title":"基于Adam Kookaburra优化的Shepard卷积神经网络的脑肿瘤分类和像素变化检测。","authors":"S Abirami, K Ramesh, K Lalitha VaniSree","doi":"10.1002/nbm.5307","DOIUrl":null,"url":null,"abstract":"<p><p>The uncommon growth of cells in the brain is termed as brain tumor. To identify chronic nerve problems, like strokes, brain tumors, multiple sclerosis, and dementia, brain magnetic resonance imaging (MRI) is normally utilized. Identifying the tumor on early stage can improve the patient's survival rate. However, it is difficult to identify the exact tumor region with less computational complexity. Also, the tumors can vary significantly in shape, size, and appearance, which complicates the task of correctly classifying tumor types and detecting subtle pixel changes over time. Hence, an Adam kookaburra optimization-based Shepard convolutional neural network (AKO-based Shepard CNN) is established in this study for the classification and pixel change detection of brain tumor. The Adam kookaburra optimization (AKO) is established by integrating the kookaburra optimization algorithm (KOA) and Adam. Here, the pre- and post-operative MRIs are pre-processed and then segmented by U-Net++. The tuning of U-Net++ is done by the bald Border collie firefly optimization algorithm (BBCFO). The bald eagle search (BES), firefly algorithm (FA), and Border collie optimization (BCO) are combined to form the BBCFO. The next operation is the feature extraction and the classification is conducted at last using ShCNN. The AKO is utilized to tune the ShCNN for obtaining effective classification results. Unlike conventional optimization algorithms, AKO offers faster convergence and higher accuracy in classification. The highest negative predictive value (NPV), true negative rate (TNR), true positive rate (TPR), positive predictive value (PPV), and accuracy produced by the AKO-based ShCNN are 89.91%, 92.26%, 93.78%, and 93.60%, respectively, using Brain Images of Tumors for Evaluation database (BITE).</p>","PeriodicalId":19309,"journal":{"name":"NMR in Biomedicine","volume":"38 2","pages":"e5307"},"PeriodicalIF":2.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Classification and Pixel Change Detection of Brain Tumor Using Adam Kookaburra Optimization-Based Shepard Convolutional Neural Network.\",\"authors\":\"S Abirami, K Ramesh, K Lalitha VaniSree\",\"doi\":\"10.1002/nbm.5307\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The uncommon growth of cells in the brain is termed as brain tumor. To identify chronic nerve problems, like strokes, brain tumors, multiple sclerosis, and dementia, brain magnetic resonance imaging (MRI) is normally utilized. Identifying the tumor on early stage can improve the patient's survival rate. However, it is difficult to identify the exact tumor region with less computational complexity. Also, the tumors can vary significantly in shape, size, and appearance, which complicates the task of correctly classifying tumor types and detecting subtle pixel changes over time. Hence, an Adam kookaburra optimization-based Shepard convolutional neural network (AKO-based Shepard CNN) is established in this study for the classification and pixel change detection of brain tumor. The Adam kookaburra optimization (AKO) is established by integrating the kookaburra optimization algorithm (KOA) and Adam. Here, the pre- and post-operative MRIs are pre-processed and then segmented by U-Net++. The tuning of U-Net++ is done by the bald Border collie firefly optimization algorithm (BBCFO). The bald eagle search (BES), firefly algorithm (FA), and Border collie optimization (BCO) are combined to form the BBCFO. The next operation is the feature extraction and the classification is conducted at last using ShCNN. The AKO is utilized to tune the ShCNN for obtaining effective classification results. Unlike conventional optimization algorithms, AKO offers faster convergence and higher accuracy in classification. The highest negative predictive value (NPV), true negative rate (TNR), true positive rate (TPR), positive predictive value (PPV), and accuracy produced by the AKO-based ShCNN are 89.91%, 92.26%, 93.78%, and 93.60%, respectively, using Brain Images of Tumors for Evaluation database (BITE).</p>\",\"PeriodicalId\":19309,\"journal\":{\"name\":\"NMR in Biomedicine\",\"volume\":\"38 2\",\"pages\":\"e5307\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NMR in Biomedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/nbm.5307\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOPHYSICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NMR in Biomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/nbm.5307","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
摘要
大脑中罕见的细胞生长被称为脑瘤。为了识别慢性神经问题,如中风、脑肿瘤、多发性硬化症和痴呆,通常使用脑磁共振成像(MRI)。早期发现肿瘤可以提高患者的生存率。然而,在计算复杂度较低的情况下,难以准确识别肿瘤区域。此外,肿瘤在形状、大小和外观上可能有很大的变化,这使得正确分类肿瘤类型和检测随时间变化的细微像素的任务变得复杂。因此,本研究建立了基于Adam kookaburra优化的Shepard卷积神经网络(AKO-based Shepard CNN),用于脑肿瘤的分类和像素变化检测。将笑翠鸟优化算法(KOA)与Adam算法相结合,建立了Adam笑翠鸟优化算法(AKO)。在这里,术前和术后mri被预处理,然后用U-Net++进行分割。U-Net++的调优是由秃边牧羊犬萤火虫优化算法(BBCFO)完成的。将秃鹰搜索(BES)、萤火虫算法(FA)和边境牧羊犬优化算法(BCO)相结合,形成BBCFO。接下来进行特征提取,最后使用ShCNN进行分类。利用AKO对ShCNN进行调优,获得有效的分类结果。与传统的优化算法不同,AKO提供更快的收敛和更高的分类精度。基于ako的ShCNN的最高阴性预测值(NPV)、真阴性率(TNR)、真阳性率(TPR)、阳性预测值(PPV)和准确率分别为89.91%、92.26%、93.78%和93.60%,使用Brain Images of tumor for Evaluation database (BITE)。
Classification and Pixel Change Detection of Brain Tumor Using Adam Kookaburra Optimization-Based Shepard Convolutional Neural Network.
The uncommon growth of cells in the brain is termed as brain tumor. To identify chronic nerve problems, like strokes, brain tumors, multiple sclerosis, and dementia, brain magnetic resonance imaging (MRI) is normally utilized. Identifying the tumor on early stage can improve the patient's survival rate. However, it is difficult to identify the exact tumor region with less computational complexity. Also, the tumors can vary significantly in shape, size, and appearance, which complicates the task of correctly classifying tumor types and detecting subtle pixel changes over time. Hence, an Adam kookaburra optimization-based Shepard convolutional neural network (AKO-based Shepard CNN) is established in this study for the classification and pixel change detection of brain tumor. The Adam kookaburra optimization (AKO) is established by integrating the kookaburra optimization algorithm (KOA) and Adam. Here, the pre- and post-operative MRIs are pre-processed and then segmented by U-Net++. The tuning of U-Net++ is done by the bald Border collie firefly optimization algorithm (BBCFO). The bald eagle search (BES), firefly algorithm (FA), and Border collie optimization (BCO) are combined to form the BBCFO. The next operation is the feature extraction and the classification is conducted at last using ShCNN. The AKO is utilized to tune the ShCNN for obtaining effective classification results. Unlike conventional optimization algorithms, AKO offers faster convergence and higher accuracy in classification. The highest negative predictive value (NPV), true negative rate (TNR), true positive rate (TPR), positive predictive value (PPV), and accuracy produced by the AKO-based ShCNN are 89.91%, 92.26%, 93.78%, and 93.60%, respectively, using Brain Images of Tumors for Evaluation database (BITE).
期刊介绍:
NMR in Biomedicine is a journal devoted to the publication of original full-length papers, rapid communications and review articles describing the development of magnetic resonance spectroscopy or imaging methods or their use to investigate physiological, biochemical, biophysical or medical problems. Topics for submitted papers should be in one of the following general categories: (a) development of methods and instrumentation for MR of biological systems; (b) studies of normal or diseased organs, tissues or cells; (c) diagnosis or treatment of disease. Reports may cover work on patients or healthy human subjects, in vivo animal experiments, studies of isolated organs or cultured cells, analysis of tissue extracts, NMR theory, experimental techniques, or instrumentation.